Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding

Journal of Medicinal Chemistry

Volumn 42, Issue 17, 1999, Pages 3289-3299

  Sawa, Eiji ^a   Takahashi, Motoo ^a   Kamishohara, Masaru ^a   Tazunoki, Tetsushi ^a   Kimura, Kaname ^a   Arai, Midori ^a   Miyazaki, Tetsuko ^a   Kataoka, Shiro ^a   Nishitoba, Tsuyoshi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONYL DERIVATIVE; ESTER DERIVATIVE; FAS ANTIGEN; TRIPEPTIDE DERIVATIVE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

ANTIBODIES; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0033607013     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980617f     Document Type: Article

References (19)

1. Smith, C. A.; Farran, T.; Goodwill, R. G. The TNF Receptor Superfamily of Cellular and Viral Proteins: Activation, Co-stimulation, and Death. Cell 1994, 76, 959-962.
2. Yonehara, S.; Ishii, A.; Yonehara, M. A Cell-killing Monoclonal Antibody (anti-Fas) to a Cell Surface Antigen Co-downregulated with the Receptor of Tumor Necrosis Factor. J. Exp. Med. 1989, 169, 1747-1756.
3. Trauth, B. C.; Klas, C.; Peters, A. M. J.; Matzku, S.; Möller, P.; Falk, W.; Debatin, K.-M.; Krammer, P. H. Monoclonal Antibody-mediated Tumor Regression by Induction of Apoptosis. Science 1989, 245, 301-305.
4. Itoh, N.; Yonehara, S.; Ishii, A.; Yonehara, M.; Mizushima, S.; Sameshima, M.; Hase, A.; Sato, Y.; Nagata, S. The Polypeptide Encoded by the cDNA for Human Cell Surface Antigen Fas Can Mediate Apoptosis. Cell 1991, 66, 233-243.
5. Watanabe-Fukunaga, R.; Brannan, C. I.; Copeland, N. G.; Jenkins, N. A.; Nagata, S. Lymphoproliferation Disorder in Mice Explained by Defects in Fas Antigen That Mediates Apoptosis. Nature 1992, 356, 314-317.
6. Takahashi, T.; Tanaka, M.; Brannan, C. I.; Jenkins, N. A.; Copeland, N. G.; Suda, T.; Nagata, S. Generalized Lymphoproliferative Disease in Mice, Caused by a Point Mutation in the Fas Ligand. Cell 1994, 76, 969-976.
7. Westendorp, M. O.; Frank, R.; Ochsenbauer, C.; Stricker, K.; Dhein, J.; Walczak, H.; Debatin, K.-M.; Krammer, P. H. Sensitization of T Cells to CD95-mediated Apoptosis by HIV-1 Tat and gp120. Nature 1996, 375, 497-500.
8. Sato, T.; Irie, S.; Ktada, S.; Reed, J. C. FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas. Science 1995, 268, 411-415.
9. Chinnaiyan, A. M.; O'Rourke, K.; Tewari, M.; Dixit, V. M. FADD, A Novel Death Domain-containing Protein, Interacts with the Death Domain of Fas and Initiates Apoptosis. Cell 1995, 81, 505-512.
10. Boldin, M. P.; Varfolomeev, E. E.; Pancer, Z.; Mett, I. L.; Camonis, J. H.; Wallach, D. A Novel Protein That Interacts with the Death Domain of Fas/APO1 Contains a Sequence Motif Related to the Death Domain. J. Biol. Chem. 1995, 270, 7795-7798.
11. Kischkel, F. C.; Hellbardt, S.; Behrmann, I.; Germer, M.; Pawlita, M.; Krammer, P. H.; Peter, M. E. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated Proteins from a Death-inducing Signaling Complex (DISC) with the Receptor. EMBO J. 1995, 14, 5579-5588.
12. Stanger, B. Z.; Leder, P.; Lee, T.-H.; Kim, E.; Seed, B. RIP: A Novel Protein Containing a Death Domain That Interacts with Fas/APO-1 (CD95) in Yeast and Causes Cell Death. Cell 1995, 81, 513-523.
13. Ungefroren, H.; Voss, M.; Jansen, M.; Roeder, C.; Henne-Bruns, D.; Kremer, B.; Kalthoff, H. Human Pancreatic Adenocarcinomas Express Fas and Fas Ligand Yet Are Resistant to Apoptosis. Cancer Res. 1998, 58, 1741-1749.
14. Mori, S.; Murakami-Mori, K.; Jewett, A.; Nakamura, S.; Bonavida, B. Resisitance of AIDS-associated Kaposi's Sacroma Cell to Fas-madiated Apoptosis. Cancer Res. 1996, 56, 1874-1879.
15. We herein define the positions of the C-terminal six amino acids (Glu-Ile-Gln-Ser-Leu-Val) of Fas in ascending order as Val 1st, Leu 2nd, Ser 3rd, Gln 4th, Ile 5th, and Glu 6th.
16. Yanagisawa, J.; Takahashi, M.; Kanki, H.; Yano-Yanagisawa, H.; Tazunoki, T.; Sawa, E.; Nishitoba, T.; Kamishohara, M.; Kobayashi, E.; Kataoka, S.; Sato, T. The Molecular Interaction of Fas and FAP-1. J. Biol. Chem. 1997, 272, 8539-8545.
17. Doyle, D. A.; Lee, A.; Lewis, J.; Kim, E.; Sheng, M.; MacKinnon, R. Crystal Structures of a Complexed and Peptide-free Membrane Protein-binding Domain: Molecular Basis of Peptide Recognition by PDZ. Cell 1996, 85, 1067-1076.
18. Saras, J.; Heldin, C.-H. PDZ Domains Bind Carboxy-terminal Sequences of Target Proteins. TIBS (Trends Biosci.) 1996, 21, 455-458.
19. Songyang, Z.; Fanning, A. S.; Fu, C.; Xu, J.; Marfatia, S. M.; Chishti, A. H.; Crompton, A.; Chan, A. C.; Anderson, J. M.; Cantley, L. C. Recognition of Unique Carboxy-terminal Motifs by Distinct PDZ Domains. Science 1997, 275, 73-77.